Sign in

NCT05563623Recruiting

The Beijing Angle Closure Progression Study

The Beijing Angle Closure Progression Study (BAPS)

Source: ClinicalTrials.gov · Last updated 3 Oct 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The Beijing angle closure progression study (BAPS) aims to explore the 5-year incidence of PACS progressing to PAC or PACG and to determine the possible risk factors of disease progression, which may provide the evidence for choosing the accurate strategies in the management of PACS.

Status (registry)
Recruiting
Study type
Observational
Enrollment
825 (estimated)
First submitted
26 Sept 2022
Start date
4 Aug 2022
Primary completion date
31 Dec 2025
Lead sponsor
Peking University People's Hospital
Diseases
Glaucoma
NCT number
NCT05563623

What you commit to

  • Study type: Observational
  • Planned participants: 825
  • From 4 Aug 2022 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous intraocular surgery or laser treatment, such as cataract surgery, laser trabeculoplasty, trabeculectomy, laser peripheral iridectomy, and laser iridoplasty
  • Sign of prior acute attack, such as glaucomatous fleck, keratic precipitates, or iris atrophy.

Other illness

  • Severe health problems precluding follow-up such as end-stage heart disease, kidney disease, or lung disease, or terminal cancer.
  • Severe eye diseases, such as cataract, macular disease, and retinal detachment.

Other

  • Any evidence of primary angle closure (a narrow angle as defined above, but with PAS and/or IOP \> 21 mmHg) or primary angle closure glaucoma (visual field defect or glaucomatous optic neuropathy).
  • Anterior segment structural abnormalities shown by examination, such as iris or ciliary body tumor.

Who the study is looking for

  • "Static" gonioscopy identifying 6 or more clock hours of angle circumference in which the posterior (usually pigmented) trabecular meshwork cannot be seen in both eyes with no peripheral anterior synechiae, and normal intraocular pressure (IOP), optic nerve and visual field.
  • Able to provide informed consent

Age in the registry: 40 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Peking University People's Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.